Steven J Pitts

Title: Steven J Pitts: Innovator in Immune Regulation

Introduction

Steven J Pitts is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies. With a total of 2 patents, Pitts has focused on developing methods to manipulate immune regulatory functions.

Latest Patents

Pitts' latest patents include the development of Anti-CD200R1 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to the human CD200R1 receptor protein (hu-CD200R1). These antibodies are capable of decreasing, inhibiting, and/or fully blocking immune regulatory effects mediated by hu-CD200R1. The patent also outlines methods for using these antibodies to treat diseases and conditions that respond to the modulation of immune regulatory functions mediated by CD200 binding to CD200R1.

Career Highlights

Steven J Pitts is currently employed at 23andMe, Inc., where he continues to advance his research in immunology. His work has implications for various therapeutic applications, particularly in treating conditions that involve immune system dysregulation.

Collaborations

Pitts has collaborated with notable colleagues, including Yu Chen and Jilean Beth Fenaux, contributing to a dynamic research environment that fosters innovation.

Conclusion

Steven J Pitts is a prominent figure in the field of immunology, with a focus on developing innovative antibody therapies. His contributions are paving the way for new treatments that could significantly impact patient care.